Comparative in vitro activities of seven new beta-lactams, alone and in combination with beta-lactamase inhibitors, against clinical isolates resistant to third generation cephalosporins

Braz J Infect Dis. 2006 Feb;10(1):22-5. doi: 10.1590/s1413-86702006000100005. Epub 2006 Jun 2.

Abstract

We examined the drug susceptibility pattern of Gram-negative bacilli to seven new beta-lactams. A total of 277 non-duplicate gramnegative bacilli strains belonging to the Enterobacteriaceae family, Pseudomonas and Acinetobacter species, isolated from various clinical samples were tested for susceptibility to imipenem, piperacillin/tazobactam, cefoperazone/sulbactam, ticarcillin/clavulanate, cefdinir, cefepime and cefpirome with the disk diffusion technique. The percentage resistance was low for imipenem (7.2%), piperacillin/tazobactam (2.8%), cefoperazone/sulbactam (5.4%). However, a high frequency of resistance was observed to ticarcillin/clavulanate (83.9%), cefdinir (70.6%), cefepime (45.5%) and cefpirome (84.4%). We conclude that imipenem, piperacillin/tazobactam and cefoperazone/sulbactam are effective antibiotics in our environment, whereas ticarcillin/clavulanate, cefdinir, cefepime and cefpirome are relatively uneffective.

Publication types

  • Comparative Study

MeSH terms

  • Acinetobacter / drug effects
  • Anti-Bacterial Agents / pharmacology*
  • Cephalosporin Resistance
  • Drug Therapy, Combination
  • Enterobacteriaceae / drug effects
  • Enzyme Inhibitors / pharmacology*
  • Gram-Negative Bacteria / drug effects*
  • Humans
  • Microbial Sensitivity Tests / methods
  • Pseudomonas / drug effects
  • beta-Lactamase Inhibitors*
  • beta-Lactams / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Enzyme Inhibitors
  • beta-Lactamase Inhibitors
  • beta-Lactams